5-Fluorouracil

Specifications

51-21-8CAS Number

200-085-6EC Number

5-fluoro-1H-pyrimidine-2,4-dioneIUPAC Name

C4H3FN2O2Chemical Formula

130.08 g/molMolecular Weight

5-Fluorouracil; fluorouracil; 51-21-8; Efudex; Fluracil; Fluoroblastin; Carzonal; Queroplex; Fluril; Phthoruracil; Arumel; Timazin; Fluracilum; Ulup; 5-Fluoracil; Fluorouracilum; Fluro Uracil; 5 Fluorouracil; 5-Fluoruracil; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; Fluorouracilo; Ftoruracil; Efurix; Effluderm (free base); Fluroblastin; 5-Fluoropyrimidine-2,4-dione; Fluoro-uracile; Fluoro-uracilo; Uracil, 5-fluoro-; 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-; Ro 2-9757; 5-Faracil; Cinco FU; Fluorouracile; NSC-19893; 2,4-Dioxo-5-fluoropyrimidine; Fluorouricil; Tolak; Ro-2-9757; 5-Fluoropyrimidin-2,4-diol; NSC 19893; DTXSID2020634; U-8953; Fluouracil; Fluoro Uracil; 5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione; 5-Fluracil; U3P01618RT; NSC19893; Ro-29757; DTXCID40634; CHEBI:46345; Flurodex; Haemato fu; Fluorouracil GRY; 5 FU Lederle; Fluoro Uracile ICN; Fluoro-Uracile ICN; 5 FU medac; 5 HU Hexal; Dakota, Fluorouracile; 5 Fluorouracil biosyn; Flurablastin; AccuSite; 5 Fluorouracilum; Fluoro-uracil roche; RefChem:56970; L01BC02; 5-Fluoro-2,4(1H, 3H)-pyrimidinedione; 200-085-6; Fluoruracil; 5-FU; Fluoroplex; Adrucil; Carac; 5-fluoropyrimidine-2,4(1H,3H)-dione; Kecimeton; 5-fluoro-1H-pyrimidine-2,4-dione; Efudix; Fluri; 5-fluoropyrimidine-2,4-diol; 2,4-Dihydroxy-5-fluoropyrimidine; 5-Fluor-2,4-pyrimidindiol; 5-fluoro uracil; 5-fluoro-uracil; 5-Ftouracyl; Fluorouracil, 5-; 5-Fluoro-2,4-pyrimidinedione; 191047-65-1; 5-Fluor-2,4-dihydroxypyrimidin; MFCD00006018; FU; CHEMBL185; MLS000069498; 5 FU; 191047-64-0; 191115-88-5; 5FU; Phtoruracil; URF; NCGC00015442-02; Effluderm; SMR000038082; Fluorouracile [DCIT]; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoruracil [German]; 1004-03-1; Fluorouracilum [INN-Latin]; Fluorouracilo [INN-Spanish]; Fluorouracil Cream; CAS-51-21-8; Fluoroplex (TN); 5-Fluor-2,4-pyrimidindiol [Czech]; Adrucil (TN); 5-fluoro-1,3-dihydropyrimidine-2,4-dione; CCRIS 2582; Carac (TN); 5-Fluor-2,4-dihydroxypyrimidin [Czech]; HSDB 3228; SR-01000075881; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; EINECS 200-085-6; 5-Fluor-2,4(1H,3H)-pyrimidindion; 2,4-Pyrimidinediol, 5-fluoro- (9CI); inhibits thymilidate synthetase; UNII-U3P01618RT; 2,4-Dioxo-5-fluoropryimidine; 5-fluorourasil; AI3-25297; Fluorouracil RS; 5-florouracil; 5-fluorouacil; 5-FU (TN); Fluorouracil CRS; 1upf; 5F-uracil; U 8953; Fluorouracil; 5-Fluoropyrimidine-2,4(1H,3H)-dione; Flucytosine Imp. A (EP); Flucytosine Impurity A; Adrucil (ICN); 2794-13-0; Adrucil (Fluorouracil); Fluorouracil [USAN:USP:INN:BAN:JAN]; Spectrum_000841; Opera_ID_134; 5-Fluorouracil, 99%; Spectrum2_000076; Spectrum3_000434; Spectrum4_000557; Spectrum5_000718; WLN: T6MVMVJ EF; FLUOROURACIL [MI]; Lopac-F-6627; F0151; 5-Fluorouracil (5-FU); FLUOROURACIL [INN]; FLUOROURACIL [JAN]; 5-Fluorouracil (Standard); UPCMLD-DP130; EC 200-085-6; F 6627; FLUOROURACIL [HSDB]; FLUOROURACIL [USAN]; SCHEMBL3646; 5-fluorpyrimidin-2,4-diol; FLUOROURACIL [VANDF]; Folfox component fluorouracil; Lopac0_000536; BSPBio_002048; FLUOROURACIL [MART.]; KBioGR_001253; KBioSS_001321; MLS002415705; DivK1c_000054; FLUOROURACIL [USP-RS]; FLUOROURACIL [WHO-DD]; FLUOROURACIL [WHO-IP]; SCHEMBL592897; SPECTRUM1500305; SPBio_000291; 5-FLUOROURACIL [IARC]; 5-fluoro-2,4-dioxo-pyrimidin; 5-fluoro-pyrimidine-2,4-diol; GTPL4789; orb1310103; orb3141274; SCHEMBL2733944; SCHEMBL8012255; SCHEMBL10746579; UPCMLD-DP130:001; Fluorouracil (JP18/USP/INN); HMS500C16; KBio1_000054; KBio2_001321; KBio2_003889; KBio2_006457; KBio3_001268; 5-Fluoro-2,3H)-pyrimidinedione; 5-FLUOROURACIL [WHO-IP]; 2,4-Pyrimidinedione, 5-fluoro-; NINDS_000054; FLUOROURACIL [ORANGE BOOK]; GLXC-07719; HMS1920O18; HMS2090I04; HMS2091F19; HMS3259O03; HMS3261L13; HMS3654K22; HMS3715H03; HMS3865L03; HMS5079C17; Pharmakon1600-01500305; FLUOROURACIL [EP MONOGRAPH]; 5-Fluorouracil, analytical standard; MSK10715; TCA94195; 2,3H)-Pyrimidinedione, 5-fluoro-; 5-Fluorouracil - Bio-X trade mark; Fluorouracil (5-Fluoracil, 5-FU); Fluorouracil (5-Fluoracil; 5-FU); FLUOROURACIL [USP MONOGRAPH]; Tox21_110150; Tox21_202335; Tox21_300112; Tox21_500536; BDBM50340677; CCG-39879; DL-399; EBC-00529; EBC-44298; EBC-50070; HY-90006R; NSC757036; NSC816997; s1209; SBB085751; STK297802; STL367375; FLUOROURACILUM [WHO-IP LATIN]; AKOS000119162; AKOS003237897; AKOS008044307; Tox21_110150_1; CS-0993; DB00544; FF05372; KS-5129; LP00536; NC00454; NSC-757036; NSC-816997; SDCCGSBI-0050519.P005; FLUCYTOSINE IMPURITY A [WHO-IP]; Fluorouracil; Flucytosine EP Impurity A; IDI1_000054; NCGC00015442-01; NCGC00015442-03; NCGC00015442-04; NCGC00015442-05; NCGC00015442-06; NCGC00015442-07; NCGC00015442-08; NCGC00015442-09; NCGC00015442-10; NCGC00015442-11; NCGC00015442-12; NCGC00015442-15; NCGC00015442-16; NCGC00015442-24; NCGC00015442-30; NCGC00091349-01; NCGC00091349-02; NCGC00091349-03; NCGC00091349-04; NCGC00091349-05; NCGC00091349-07; NCGC00091349-08; NCGC00254023-01; NCGC00259884-01; NCGC00261221-01; AC-11201; BF166014; EMTRICITABINE IMPURITY F [WHO-IP]; HY-90006; NCI60_001652; SRI-10792-04; SRI-10792-05; SRI-10792-06; SRI-10792_07; SRI-10792_08; 5-Fluoro-1H-pyrimidine-2,4-dione(5FU); 5-Fluorouracil, >=99% (HPLC), powder; SBI-0050519.P004; 2(1H)-Pyrimidinone, 5-fluoro-4-hydroxy-; 4(3H)-Pyrimidinone, 5-fluoro-2-hydroxy-; 5-Fluoro-1H-pyrimidine-2,4-dione(5-FU); DB-051923; DB-065735; DB-268958; DB-272209; DB-297613; pyrimidine-2,4(1H,3H)-dione, 5-fluoro-; 5-Fluoro-1H-pyrimidine-2,4-dione (5-FU); EU-0100536; F4480; FLUCYTOSINE IMPURITY A [EP IMPURITY]; NS00000337; ST45025877; SW199617-3; 5-Fluoro-1H-pyrimidine-2,4-dione(5-FUra); EN300-33909; Fluorouracil, meets USP testing specifications; C07649; D00584; 5-fluoro-6-hydroxy-1,2-dihydropyrimidin-2-one; 5-Fluorouracil, Vetec(TM) reagent grade, >=99%; F003241; Q238512; W-60379; (5-fluorouracil)5-Fluoro-1H-pyrimidine-2,4-dione; 5-Fluoro-1H-pyrimidine-2,4-dione(5-fluoro uracil); SR-01000075881-1; SR-01000075881-3; SR-01000075881-5; 5-Fluoro-1H-pyrimidine-2,4-dione (5-Fluorouracil); BRD-K24844714-001-02-1; BRD-K24844714-001-24-5; BRD-K24844714-001-25-2; 5-FLUOROPYRIMIDIN-2,4(1H,3H)-DIONE [WHO-IP]; Z275128052; 5-Fluoro-1H-pyrimidine-2,4-dione(5-fluorouracil)(5-FU); 5-Fluorouracil, certified reference material, TraceCERT(R); Fluorouracil, British Pharmacopoeia (BP) Reference Standard; Fluorouracil, European Pharmacopoeia (EP) Reference Standard; Fluorouracil, United States Pharmacopeia (USP) Reference Standard; pyrimidine antimetabolite: inhibits nucleic acid replication; tetratogen; Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9Synonyms